Medtronic Ophthalmics buys CellPlant
This article was originally published in The Gray Sheet
Executive Summary
Polymer stent for glaucoma treatment will be evaluated in clinical trials pending FDA study go-ahead, firm says. Medtronic acquired the technology from Wound Healing of Oklahoma, Inc. Nov. 11. CellPlant operates as a microscopic piping system to drain excess fluid from the eye. The device complements Medtronic's Tono-Pen XL portable applanation tonometer for monitoring intraocular pressure and ENDOLaser endoscopic laser for reduction of aqueous fluid production. CellPlant is implanted beneath the trabecular flap during a trabeculectomy...